Takeshi Matsubara (Tazuke Kofukai Public Interest Foundation Medical Research Institute Kitano Hospital)

2024- Chief Director, Department of Nephrology and Dialysis, Tazuke Kofukai Public Interest Foundation Medical Research Institute Kitano Hospital

2014-2024 Lecturer, Department of Nephrology, Kyoto University Graduate School of Medicine, Kyoto, Japan

2007-2014 Assistant Professor, Department of Nephrology, Kyoto University Graduate School of Medicine, Kyoto, Japan

2006 Ph.D. in Geriatric Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan

1996 M.D. in Medicine, Kyoto University School of Medicine, Kyoto, Japan

Cancer epidemiology and management in patients undergoing dialysis

Anti-cancer drug-induced kidney injury and nephrotoxicity

Apheresis therapy: efficacy, safety, and clinical applications

Experimental nephrology, with a focus on the development of diabetic glomerulosclerosis

Toriu N, Yamamoto S, Matsubara T, et al, Cancer diagnosis and prognosis after initiation of hemodialysis: multicenter Japan CANcer and DialYsis (J-CANDY) study. Clin Kidney J. 2024 Dec 20;18(2): sfae430.

Matsubara T, Yokoi H, Yamada H, Yanagita M. Nephrotoxicity associated with anticancer agents: perspective on onconephrology from nephrologists. Int J Clin Oncol. 2023 May; 28(5): 625-636.

Muto S, Matsubara T, Inoue T, et al, Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022. Int J Clin Oncol. 2023 Oct;28(10):1259-1297.

Matsubara T, Araki M, Abe H, et al, Bone Morphogenetic Protein 4 and Smad1 Mediate Extracellular Matrix Production in the Development of Diabetic Nephropathy. Diabetes. 2015 Aug;64(8): 2978-90.